Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion

被引:16
作者
Hayano, Koichi [1 ]
Desai, Gaurav S. [1 ]
Kambadakone, Avinash R. [1 ]
Fuentes, Jorge M. [1 ]
Tanabe, Kenneth K. [2 ]
Sahani, Dushyant V. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiol, Div Abdominal Imaging & Intervent, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA
关键词
Computed tomography perfusion; hepatocellular carcinoma; angiogenesis; metastatic liver tumor; COMPUTED-TOMOGRAPHY; CONTRAST ENHANCEMENT; ANGIOGENESIS; BIOMARKERS; PARAMETERS; MANAGEMENT; DISEASE; TIME;
D O I
10.1102/1470-7330.2013.0040
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the diagnostic value of computed tomography perfusion (CTP) in the distinction of hepatocellular carcinomas (HCCs) from metastatic liver tumors. Materials and methods: CTP data from 90 liver tumors (HCC 38, metastasis 52) in 31 patients (16 men and 15 women; mean age 60.3 years) were studied. CTP was performed on a 16/64 multidetector-row CT scanner using a 30-s duration cine acquisition after rapid bolus injection (5-7 ml/s) of 50-70 ml of iodinated contrast medium. The CTP data were analyzed using a deconvolution model. Metastatic tumors were grouped into hypovascular (n=36) and hypervascular (n=16) tumors. Results and conclusion: The hypovascular metastases showed a significantly lower blood flow (BF) and blood volume (BV), and higher mean transit time (MTT) than HCC (all P<0.0001). BF, BV, and MTT of HCCs were substantially lower than those of hypervascular metastases (P=0.02, P< 0.0001, P=0.03, respectively). A receiver-operating characteristic analysis showed that BV was a useful marker to distinguish HCCs from hypervascular metastases.
引用
收藏
页码:512 / 519
页数:8
相关论文
共 35 条
[1]   Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI [J].
Abdullah, Siraj Saadaldin ;
Pialat, Jean Baptiste ;
Wiart, Marlene ;
Duboeuf, Francois ;
Mabrut, Jean-Yves ;
Bancel, Brigitte ;
Rode, Agnes ;
Ducerf, Christian ;
Baulieux, Jacques ;
Berthezene, Yves .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 28 (02) :390-395
[2]   Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT [J].
Baron, RL ;
Oliver, JH ;
Dodd, GD ;
Nalesnik, M ;
Holbert, BL ;
Carr, B .
RADIOLOGY, 1996, 199 (02) :505-511
[3]   Hypervascular Liver Masses on Contrast-Enhanced Ultrasound: The Importance of Washout [J].
Bhayana, Deepak ;
Kim, Tae Kyoung ;
Jang, Hyun-Jung ;
Burns, Peter N. ;
Wilson, Stephanie R. .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (04) :977-983
[4]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[5]   Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography [J].
Chen, Mai-Lin ;
Zeng, Qing-Yu ;
Huo, Jian-Wei ;
Yin, Xiao-Ming ;
Li, Bao-Ping ;
Liu, Jian-Xin .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (28) :3532-3537
[6]  
Choi BI, 1995, CANCER, V76, P2433
[7]  
Choi BY, 2005, J CLIN GASTROENTEROL, V39, P401, DOI 10.1097/01.mcg.0000159226.63037.a2
[8]   HEPATIC CT CONTRAST ENHANCEMENT - EFFECT OF DOSE, DURATION OF INFUSION, AND TIME ELAPSED FOLLOWING INFUSION [J].
DEAN, PB ;
VIOLANTE, MR ;
MAHONEY, JA .
INVESTIGATIVE RADIOLOGY, 1980, 15 (02) :158-161
[9]   CONTRAST ENHANCEMENT TECHNIQUE FOR DYNAMIC HEPATIC COMPUTED TOMOGRAPHIC SCANNING [J].
FOLEY, WD ;
BERLAND, LL ;
LAWSON, TL ;
SMITH, DF ;
THORSEN, MK .
RADIOLOGY, 1983, 147 (03) :797-803
[10]   Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography - Effect of acquisition time and implications for protocols [J].
Goh, V ;
Halligan, S ;
Hugill, JA ;
Gartner, L ;
Bartram, CI .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2005, 29 (01) :59-63